Academic Biotech Target Target academic and biotech labs focused on cellular interactions and therapy discovery, where Enrich's benchtop, microfluidics free platform can shorten study timelines and simplify workflows in cancer, immunology, and stem cell research.

CRO Partnership Position Enrich for contract research organizations seeking high-throughput cell imaging and analysis with lower upfront risk and operating costs than microfluidics based tools, enabling faster project turnarounds.

Regional Growth Capitalize on the Connecticut base by engaging Northeast universities and biotech firms through on-site demos, regional support, and scalable installation plans to accelerate pilot programs into commercial adoption.

Competitive Differentiation Differentiate from traditional microfluidic solutions by highlighting ease of use, reduced maintenance, compact benchtop footprint, and total cost of ownership to attract labs lacking specialized microfluidics expertise.

Expansion Partnerships Unlock cross-sell opportunities by aligning with cancer, immunology, and stem cell programs pursuing precision medicine, long-term interaction studies, and translational therapies, and explore partnerships with pharma and larger biotech players.